SVP Worldwide Announces Global Launch of Three New PFAFF® Sewing Machines: creative expression™ 750, quilt expression™ 725, and expression™ 715
SVP Worldwide, the parent company of PFAFF®, SINGER®, and HUSQVARNA® VIKING® sewing brands, today announced the highly anticipated global launch of three new PFAFF sewing machines: the creative expression 750, quilt expression 725, and expression 715. These machines combine precision engineering, cutting-edge technology, and the timeless craftsmanship PFAFF is known for.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250814267636/en/

SVP Worldwide, the parent company of PFAFF (R), launches three new sewing machines: the creative expression 750, quilt expression 725 and expression 715. The machines combine precision engineering, cutting-edge technology, and the timeless craftsmanship PFAFF is known for globally.
The new models will be available for purchase beginning August 14, 2025 on PFAFF.com and at authorized PFAFF Dealer locations across the United States and Europe. Expanded global distribution in Latin America and Asia Pacific is planned throughout Q3 and Q4 of 2025.
"This launch represents an exciting new chapter for PFAFF and for passionate sewists around the world," said Rob Will, CEO of SVP Worldwide. "These three machines are designed to inspire creativity and confidence, offering the precision and innovation that our customers expect from the PFAFF brand. We can’t wait to see the extraordinary projects our ‘PFAFFies’ will bring to life with this new lineup."
The new expression series machines showcase advanced features tailored to both serious hobbyists and professional sewists. All models offer:
- Built-in connectivity to the CREATIVATE™ digital platform of creative tools
- Large color capacitive touch screens for an intuitive, modern sewing experience
- Automatic Needle Threaders eliminate threading frustration
- Exclusive PFAFF stitch techniques for distinctive embellishments
The creative expression 750 and quilt expression 725 also feature adjustable laser sewing guidance, enabling users to achieve unmatched accuracy for complex projects.
"The new PFAFF expression series brings together precision and innovation in a way that truly elevates the sewing experience," said Jason Zielke, Chief Product and Technology Officer at SVP Worldwide. "We are especially proud of the new Hoop Scanning feature on the creative expression 750, which allows a sewist to see their hooped project on the 8” color touch screen for a more accurate placement of the embroidery before stitching."
The launch of the PFAFF creative expression 750, quilt expression 725, and expression 715 reaffirms SVP Worldwide’s commitment to empowering creators worldwide with products that push the boundaries of sewing technology and innovation.
For more information or to locate a dealer, visit www.pfaff.com.
PFAFF, SINGER, VIKING, CREATIVE EXPRESSION, QUILT EXPRESSION, EXPRESSION and CREATIVATE are exclusive trademarks of Singer Sourcing Limited LLC or its Affiliates. HUSQVARNA and the “H” Crown Device are trademarks of Husqvarna AB and are used under license. © 2025 Singer Sourcing Limited LLC or its Affiliates. All rights reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250814267636/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy9.12.2025 14:05:00 CET | Press release
Leading European Hospital System Begins Offering On-site Liquid Biopsy Testing Based on Proprietary Guardant360® CDx Technology Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the successful launch of FPG 360, an in-house liquid biopsy testing service at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Policlinico Gemelli) in Rome, Italy. This partnership is the latest in a series of public-private partnerships Guardant Health has formed with top-tier European academic and research hospitals that embed its groundbreaking technology with existing care pathways to expand access to more cancer patients. Policlinico Gemelli will offer on-site liquid biopsy testing based on Guardant360® CDx technology. The collaboration expands access to precision oncology diagnostics and supports both routine care and clinical research. FPG 360 is one of the first dedicated liquid biopsy testing facilities in Italy housed within a hospital system. P
NTT DATA appoints CEO of newly established AI Company NTT DATA AIVista, Inc.9.12.2025 14:00:00 CET | Press release
Dr. Bratin Saha joins NTT DATA AIVista, Inc., bringing extensive experience in AI, infrastructure, platforms and solutions NTT DATA AIVista, Inc. established in Silicon Valley to help NTT operating companies accelerate the launch and scaling of AI native businesses NTT DATA, a global leader in AI, digital business and technology services, today announced the appointment of Dr. Bratin Saha as CEO of the newly established AI Company, NTT DATA AIVista, Inc., effective Dec 1, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251209189202/en/ Dr. Bratin Saha, newly appointed CEO of NTT DATA AIVista, Inc. Saha brings deep expertise in AI, infrastructure, platforms and solutions; scaling new businesses and significant ecosystem relationships. Prior to joining NTT DATA, he held executive positions at NVIDIA, Amazon Web Services (AWS) and most recently DigitalOcean. At NVIDIA, Saha served as Vice President of Software Infrastructu
Aqemia to Attend the 44th Annual J.P. Morgan Healthcare Conference 20269.12.2025 14:00:00 CET | Press release
Aqemia, a drug invention company combining generative AI and quantum-inspired physics, announces it will attend and hold 1x1 meetings at the 44th Annual J.P. Morgan Healthcare Conference, taking place at The Westin St. Francis in San Francisco from January 12 to 15, 2026. Aqemia will be represented by Maximilien Levesque, CEO and co-founder, Emmanuelle Martiano, COO and co-founder, and Théa Vu-Bignand, VP Finance. Powered by QEMI, its proprietary physics-based generative AI engine for therapeutic molecule invention, Aqemia designs novel drug candidates in a repeatable, efficient, and scalable way. The company focuses on advancing its internal preclinical pipeline while establishing partnerships that validate its platform and scientific differentiation, with the ambition to accelerate the delivery of new therapies in areas of high unmet medical need. About Aqemia Aqemia is a drug invention company dedicated to creating novel molecules to address unmet medical needs. Its proprietary QEMI
Avia Expands to Europe with New German Subsidiary9.12.2025 14:00:00 CET | Press release
AviaGames, a leading global mobile skill-based gaming platform, today announced the establishment of a new subsidiary in Germany. Games industry veteran Michelle Zou has been appointed to head the new entity, overseeing market expansion and investment initiatives across Europe. This move marks a significant milestone in AviaGames’ global growth strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251209920028/en/ Games industry veteran Michelle Zou has been appointed to head the AviaGames German subsidiary, overseeing market expansion and investment initiatives across Europe. AviaGames has rapidly emerged as one of the most prominent interactive entertainment companies worldwide, with a global user base of tens of millions of players across North America, and Europe, spanning North America and beyond. The company is especially recognized for its popularity among female players and for delivering high-quality, skill-based
ExaGrid Wins 3 New Industry Awards at the MSP Channel Awards9.12.2025 14:00:00 CET | Press release
Awards highlight ExaGrid’s achievements in the MSP sector ExaGrid®, the industry’s only Tiered Backup Storage solution with AI-Powered Retention Time-Lock (RTL) that includes a non-network-facing tier (tiered air gap), Auto Detect & Guard, delayed deletes and immutability for ransomware recovery, today announced that the company was honored with three awards during the 1st annual MSP Channel Awards ceremony, held in London on December 3, 2025, including: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251209577454/en/ Photo courtesy of MSP Channel Awards. Backup & DR Innovation of the Year Storage Hardware Innovation of the Year Storage Vendor of the Year Many Managed Service Providers (MSPs) use ExaGrid Tiered Backup Storage to offer their customers Backup as a Service (BaaS), Disaster Recovery as a Service (DRaaS), and IT Data Center Outsourcing. In 2025, ExaGrid released new features that help MSPs track their customers’ d
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom